API | cintredekin besudotox

cintredekin besudotox Report issue

Biologics Recombinant protein Experimental

AACT ChEMBL DrugBank MeSH

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
cintredekin besudotox

More Chemistry

Pharmacology

Mechanisms of Action:
- Interleukin-13 receptor subunit alpha-1 (Homo sapiens) ^UniProt
- Interleukin-4 receptor subunit alpha (Homo sapiens) ^UniProt
- Interleukin-13 receptor subunit alpha-2 (Homo sapiens) ^UniProt
- Interleukin-13 (Homo sapiens) ^UniProt
Multi-specific: No
Payload: pseudomonas exotoxin
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

cintredekin besudotox | il-13-pe | il13-pe38 | il13-pe38qqr

Organizations (9)

Research & Development (9)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (7)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (7)

Adrenocortical Carcinoma (Phase 1)

Astrocytoma (Phase 1/Phase 2)

Brain Neoplasms (Phase 1/Phase 2)

Glioblastoma (Phase 3)

Glioma (Phase 1/Phase 2)

Neoplasms ()

Oligodendroglioma (Phase 1)

Overview

Highest Phase: Phase 3
# of Trials: 12
# of Trial Organizations: 9

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue